Fenxia Zhu

942 total citations · 1 hit paper
30 papers, 772 citations indexed

About

Fenxia Zhu is a scholar working on Molecular Biology, Pharmacology and Plant Science. According to data from OpenAlex, Fenxia Zhu has authored 30 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Pharmacology and 5 papers in Plant Science. Recurrent topics in Fenxia Zhu's work include Natural product bioactivities and synthesis (10 papers), Alkaloids: synthesis and pharmacology (6 papers) and Microfluidic and Capillary Electrophoresis Applications (4 papers). Fenxia Zhu is often cited by papers focused on Natural product bioactivities and synthesis (10 papers), Alkaloids: synthesis and pharmacology (6 papers) and Microfluidic and Capillary Electrophoresis Applications (4 papers). Fenxia Zhu collaborates with scholars based in China and United States. Fenxia Zhu's co-authors include Xiao‐Bin Jia, Jiaquan Chen, Yingxiang Du, Tuo Shao, Shirish Barve, Jie Song, Wenke Feng, Fengyuan Li, Craig J. McClain and Yunhuan Liu and has published in prestigious journals such as Hepatology, Journal of Chromatography A and Molecules.

In The Last Decade

Fenxia Zhu

29 papers receiving 769 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice

2019 263 citations Yunhuan Liu, Kefei Chen et al. Hepatology profile →

Peers

Countries citing papers authored by Fenxia Zhu

Since Specialization

Citations

This map shows the geographic impact of Fenxia Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenxia Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenxia Zhu more than expected).

Fields of papers citing papers by Fenxia Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenxia Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenxia Zhu. The network helps show where Fenxia Zhu may publish in the future.

Co-authorship network of co-authors of Fenxia Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Fenxia Zhu. A scholar is included among the top collaborators of Fenxia Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenxia Zhu. Fenxia Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigating the mechanism and efficacy material basis of Xiehuo Xiaoying decoction for treating Graves' disease via thyroid cell apoptosis based on proteomics and molecular docking techniques 2024 ·Journal of Ethnopharmacology ·Pingping Xiang, (unknown), (unknown), (unknown), (unknown), Xiaoyang Qu, (unknown), Yu Chen, (unknown), Qifeng Wang, Rong‐Lin Zhong, (unknown), Chao Liu, Fenxia Zhu	3
2	MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3 2024 ·BMC Cancer ·Aiqin Zhao, Yunzhi Pan, (unknown), Zheng Zhi, (unknown), (unknown), (unknown), Meiying Wu, Fenxia Zhu, Sufang Zhou, Sai Ma	3
3	Melatonin Ameliorates Cadmium‐Induced Liver Fibrosis Via Modulating Gut Microbiota and Bile Acid Metabolism 2024 ·Journal of Pineal Research ·(unknown), Weili Kang, Jinyan Li, Xin Li, Peng Yang, (unknown), Zhongyu Wang, Yuanchao Wang, (unknown), Dandan Liu, Fenxia Zhu, Hong Shen, (unknown), Xingxiang Chen, Yunhuan Liu	5
4	An integrated RNA-Seq and network pharmacology approach for exploring the preventive effect of Corydalis bungeana Turcz. Extract and Acetylcorynoline on LPS-induced acute lung injury 2023 ·Journal of Ethnopharmacology ·(unknown), Yan Xiang, (unknown), Xiaoyang Qu, Jie Wu, Jun Fu, Fenxia Zhu, Hao Tang	5
5	Melatonin improves cholestatic liver disease via the gut‐liver axis 2023 ·Journal of Pineal Research ·(unknown), Jinyan Li, (unknown), Jun Fu, Yubo Wang, Weili Kang, Jinyan Liu, Fenxia Zhu, Kehe Huang, Xingxiang Chen, Yunhuan Liu	14
6	Carboxymethyl starch as a solid dispersion carrier to enhance the dissolution and bioavailability of piperine and 18β-glycyrrhetinic acid 2023 ·Drug Development and Industrial Pharmacy ·(unknown), Ruilong Li, Wenjing Wang, (unknown), Fenxia Zhu, Yi‐Ping Huang, (unknown), Zhenhai Zhang	1
7	Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice 2019 ·Molecular Metabolism ·Cuiqing Zhao, Li Liu, Qi Liu, Fengyuan Li, Lihua Zhang, Fenxia Zhu, Tuo Shao, Shirish Barve, Yiping Chen, Xiaokun Li, Craig J. McClain, Wenke Feng	39
8	Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice breakdown → 2019 ·Hepatology ·Yunhuan Liu, Kefei Chen, Fengyuan Li, Zelin Gu, Qi Liu, Liqing He, Tuo Shao, Qing Song, Fenxia Zhu, Lihua Zhang, Mengwei Jiang, Yun Zhou, Shirish Barve, Xiang Zhang, Craig J. McClain, Wenke Feng	263
9	Nauclea officinalis inhibits inflammation in LPS-mediated RAW 264.7 macrophages by suppressing the NF-κB signaling pathway 2016 ·Journal of Ethnopharmacology ·Xiaoting Zhai, Zhiyuan Zhang, Cuihua Jiang, (unknown), (unknown), Xiao‐Bin Jia, Yi Yang, Qian Ni, Shuxia Wang, Jie Song, Fenxia Zhu	59
10	Anti-inflammatory effect of the six compounds isolated from Nauclea officinalis Pierrc ex Pitard, and molecular mechanism of strictosamide via suppressing the NF-κB and MAPK signaling pathway in LPS-induced RAW 264.7 macrophages 2016 ·Journal of Ethnopharmacology ·(unknown), (unknown), (unknown), Xiaoting Zhai, Jie Song, Cuihua Jiang, Jing Wang, Hao Zhang, Xiao‐Bin Jia, Fenxia Zhu	48
11	Corydalis bungeana Turcz. attenuates LPS-induced inflammatory responses via the suppression of NF-κB signaling pathway in vitro and in vivo 2016 ·Journal of Ethnopharmacology ·Xiaoting Zhai, (unknown), Cuihua Jiang, Jie Song, Dongyu Li, Hao Zhang, Xiaobin Jia, Wei Tan, Shuxia Wang, (unknown), Fenxia Zhu	27
12	Simultaneous determination of six alkaloid components in rat plasma and its application to pharmacokinetic study of Danmu preparations by an ultra fast liquid chromatography–electrospray ionization-tandem mass spectrometry 2015 ·Journal of Chromatography B ·(unknown), Jiaquan Chen, Yong‐Gang Zhao, Xiao‐Bin Jia, Zhiyuan Zhang, Liang Feng, Hui Wang, Jingjing Wang, Fenxia Zhu	10
13	Analysis of the chemical constituents and rats metabolites after oral administration of Nauclea officinalis by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry 2015 ·Journal of Chromatography B ·Fenxia Zhu, Jiaquan Chen, Hui Wang, Xiaobin Jia, Shuxia Wang, Zhiyuan Zhang, Xiaoting Zhai, Jin‐Di Xu, Wei Tan, Qing Ning, Junfei Gu	11
14	Study of the enantioseparation capability of chiral dual system based on chondroitin sulfate C in CE 2014 ·Electrophoresis ·Jiaquan Chen, Yingxiang Du, Fenxia Zhu, Bin Chen, Qi Zhang, Shuaijing Du, Ping Li	11
15	Characterization of metabolites of 20(S)-protopanaxadiol in rats using ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry 2013 ·Journal of Chromatography B ·Xin Jin, Song‐Lin Li, Zhenhai Zhang, Fenxia Zhu, E Sun, Yingjie Wei, Xiao‐Bin Jia	12
16	A novel drug–phospholipid complex loaded micelle for baohuoside I enhanced oral absorption:in vivoandin vivoevaluations 2012 ·Drug Development and Industrial Pharmacy ·Xin Jin, Zhen-Hai Zhang, E Sun, Xiaobin Tan, Fenxia Zhu, Xiaobin Jia	40
17	Quality evaluation of Yanghuo Sanqi tablet through a simultaneous determination of five major active Flavonoids and three main saponins by HPLC-DAD-ELSD 2012 ·Acta Chromatographica ·Fenxia Zhu, Xiao‐Bin Jia, Yujiao Cai, (unknown)	3
18	Quality evaluation ofYanghuo Sanqitablet through a simultaneous determination of five major active flavonoids and three main saponins by HPLC-DAD-ELSD 2012 ·Acta Chromatographica ·Fenxia Zhu, Xiao‐Bin Jia, Yujiao Cai, (unknown)	3
19	Evaluation of the enantioselectivity of glycogen-based dual chiral selector systems towards basic drugs in capillary electrophoresis 2010 ·Journal of Chromatography A ·Jiaquan Chen, Yingxiang Du, Fenxia Zhu, Bin Chen	41
20	Glycogen: A novel branched polysaccharide chiral selector in CE 2010 ·Electrophoresis ·Jiaquan Chen, Yingxiang Du, Fenxia Zhu, Bin Chen	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact